Abstract
The study was done to know the prevalent mutations of gyrA and gyrB genes, and their significance with drug resistance in clinical isolates of Mycobacterium tuberculosis. A total of 100 ofloxacin- (OFX) resistant and 100 OFX-sensitive isolates of M. tuberculosis were consecutively selected from routine Tuberculosis laboratory. Drug resistance pattern of these isolates was recorded. MIC of OFX was tested in all these isolates by absolute concentration method. Quinolone resistance determining region (QRDR) of gyrA and gyrB genes of 320 and 428 bp, respectively, were amplified and sequenced. Sequencing data were analyzed by BLAST on NCBI with reference strain H37Rv. Of 100 OFX-sensitive isolates, 30 were pansusceptible, 28 were monoresistant, 10 were polyresistant and 32 were multidrug resistant (MDR). Among 100 OFX-resistant isolates, 19 were OFX monoresistant, 16 were polyresistant and 65 were MDR. Mutations in gyrA and gyrB genes were observed in 79% and 5% of OFX-resistant isolates, respectively. Most prevalent mutation was found at codon 94 in QRDR of gyrA gene. Double mutations found in gyrA gene and in both gyrA and gyrB genes signifies higher levels of OFX resistance. In one isolate, a substitution at codon 592 (Pro592Ser) was found as a novel mutation outside the QRDR of gyrB gene. Our findings support previous studies that the OFX resistance to M. tuberculosis is associated with mutations in the QRDR of gyrA gene; however, the level of OFX resistance may not be predicted based on the mutation patterns in the gyrA gene.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Cole, S. T. et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393, 537–544 (1998).
Takiff, H. E. et al. Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations. Antimicrob. Agents Chemother. 38, 773–780 (1994).
Yin, X. & Yu, Z. Mutation characterization of gyrA and gyrB genes in levofloxacin-resistant Mycobacterium tuberculosis clinical isolates from Guangdong Province in China. J. Infect. 61, 150–154 (2010).
Brossier, F., Veziris, N., Aubry, A., Jarlier, V. & Sougakoff, W. Detection by GenoType MTBDRsl test of complex mechanisms of resistance to second line drugs and ethambutol in multidrug resistant Mycobacterium tuberculosis complex isolates. J. Clin. Microbiol. 48, 1683–1689 (2010).
Duong, D. A. et al. Beijing genotype of Mycobacterium tuberculosis is significantly associated with high-level fluoroquinolone resistance in Vietnam. Antimicrob. Agents Chemother. 53, 4835–4839 (2009).
Canetti, G. et al. Advances in techniques of testing mycobacterial drug sensitivity and the use of sensitivity tests in tuberculosis control programmes. Bull. WHO. 41, 21–43 (1969).
Aslan, G., Tezcan, S., Serin, M. S. & Emekdas, G. Genotypic analysis of isoniazid and rifampin resistance in drug-resistant clinical Mycobacterium tuberculosis Complex isolates in Southern Turkey. Jpn J. Infect. Dis. 61, 255–260 (2008).
Singh, M. et al. In vitro effect of fluoroquinolones against Mycobacterium tuberculosis isolates from Agra & Kanpur region of north India. Indian J. Med. Res. 542–547 (2009).
Verma, J. S., Nair, D., Rawat, D. & Manzoor, N. Assessment of trends of ofloxacin resistance in Mycobacterium tuberculosis. Indian J. Med. Res. 29, 280–282 (2011).
Daniel, O. et al. Ofloxacin resistance among Mycobacterium tuberculosis isolates in two states of south-west Nigeria. Afr. J. Resp. Med. 6, 18–20 (2011).
Umubyeyi, A. N. et al. Limited fluoroquinolone resistance among Mycobacterium tuberculosis isolates from Rwanda: results of a national survey. J. Antimicrob. Chemother. 59, 1031–1033 (2007).
Cui, Z., Wang, J., Lu, J., Huang, W. & Hu, Z. Association of mutation patterns in gyrA/B genes and ofloxacin resistance levels in Mycobacterium tuberculosis isolates from East China in 2009. BMC Infect. Dis. 11, 78 (2011).
Chen, J. et al. Characterization of gyrA and gyrB mutations and fluoroquinolone resistance in Mycobacterium tuberculosis clinical isolates from Hubei Province, China. Braz. J. Infect. Dis. 16, 136–141 (2012).
Siddiqi, N. et al. Molecular characterization of multidrug-resistant isolates of Mycobacterium tuberculosis from patients in North India. Antimicrob. Agents Chemother. 46, 443–450 (2002).
Mokrousov, I. et al. Molecular characterization of ofloxacin-resistant Mycobacterium tuberculosis strains from Russia. Antimicrob. Agents Chemother. 52, 2937–2939 (2008).
Al-Mutairi, N., Ahmad, S. & Mokaddas, E. Performance comparison of four methods for rapid detection of multidrug-resistant Mycobacterium tuberculosis strains. Int. J. Tuberc. Lung Dis. 15, 110–115 (2011).
Matrat, S. et al. Functional analysis of DNA gyrase mutant enzymes carrying mutations at position 88 in the A subunit found in clinical strains of Mycobacterium tuberculosis resistant to fluoroquinolones. Antimicrob. Agents Chemother. 50, 4170–4173 (2006).
Von Groll, A. et al. Fluoroquinolone resistance in Mycobacterium tuberculosis and mutations in gyrA and gyrB. Antimicrob. Agents Chemother. 53, 4498–4500 (2009).
Escribano, I. et al. Importance of the efflux pump systems in the resistance of Mycobacterium tuberculosis to fluoroquinolones and linezolid. Chemotherapy 53, 397–401 (2007).
Devasia, R. et al. High proportion of fluoroquinolone resistant Mycobacterium tuberculosis isolates with novel gyrase polymorphisms and a gyrA region associated with fluoroquinolone susceptibility. J. Clin. Microbiol. 50, 1390 (2012).
Acknowledgements
This research work was supported by the Government of India, Ministry of Science and Technology, Department of Science and Technology, New Delhi-110016.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Singh, P., Jain, A., Dixit, P. et al. Prevalence of gyrA and B gene mutations in fluoroquinolone-resistant and -sensitive clinical isolates of Mycobacterium tuberculosis and their relationship with MIC of ofloxacin. J Antibiot 68, 63–66 (2015). https://doi.org/10.1038/ja.2014.95
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/ja.2014.95
This article is cited by
-
Direct Detection of Fluoroquinolone Resistance in Sputum Samples from Tuberculosis Patients by High Resolution Melt Curve Analysis
Current Microbiology (2024)
-
Genomic characteristics and comparative genomics of Salmonella enterica subsp. enterica serovar Schwarzengrund strain S16 isolated from chicken feces
Gut Pathogens (2022)
-
Genotypic and phenotypic characterization of Mycobacterium tuberculosis resistance against fluoroquinolones in the northeast of Iran
BMC Infectious Diseases (2020)
